Loading insider details...
Beta
Latest Form 4 (Jun 8, 2026): Grant/Award of 4,000 TNGX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | Tango Therapeutics, Inc. (TNGX) | Grant/Award | 4,000 | n/a |
| May 14, 2026 | Surrozen, Inc./DE (SRZN) | Grant/Award | 5,550 | n/a |
| Jun 9, 2025 | Tango Therapeutics, Inc. (TNGX) | Grant/Award | 6,250 | n/a |
| May 15, 2025 | Surrozen, Inc./DE (SRZN) | Grant/Award | 1,333 | n/a |
| Nov 19, 2024 | Tango Therapeutics, Inc. (TNGX) | Purchase | 10,000 | $36.2K |
| Jun 7, 2024 | Tango Therapeutics, Inc. (TNGX) | Grant/Award | 6,250 | n/a |
| Jun 7, 2024 | Surrozen, Inc./DE (SRZN) | Grant/Award | 1,333 | n/a |
| Jun 9, 2023 | Tango Therapeutics, Inc. (TNGX) | Grant/Award | 5,000 | n/a |
| May 19, 2023 | Surrozen, Inc./DE (SRZN) | Grant/Award | 20,000 | n/a |
| Jun 28, 2022 | Tango Therapeutics, Inc. (TNGX) | Grant/Award | 40,000 | n/a |